Literature DB >> 3415963

Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes.

L Stamatatos1, R Leventis, M J Zuckermann, J R Silvius.   

Abstract

Lipid vesicles with a positive surface charge have been prepared by using mixtures of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) together with low mole fractions of a cationic lipid analogue, 1,2-bis(oleoyloxy)-3-(trimethylammonio)propane (DOTAP). We have used measurements of vesicle aggregation, lipid mixing, contents mixing, and contents leakage to examine the interactions between these vesicles and similar vesicles that carry a negative surface charge. Mixtures of vesicles with opposite surface charges aggregate readily at physiological or lower ionic strengths, and the extent of this aggregation is enhanced for vesicles that contain high proportions of PE relative to PC. Mixing of lipids and aqueous contents can also be observed between such vesicles, particularly when the vesicles contain substantial proportions of PE. Surprisingly, these latter processes are strongly promoted by monovalent salts and do not proceed at very low ionic strengths. PE/DOTAP vesicles show substantial lipid mixing with negatively charged vesicles containing high proportions of phosphatidylcholine, as well as with human erythrocyte ghosts, on a time scale of a few minutes. These interactions are strongly promoted both by the presence of high levels of PE in the cationic vesicles and by the presence of complementary surface charges on the two membrane populations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415963     DOI: 10.1021/bi00411a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

Review 1.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

Review 2.  Spontaneous lipid transfer between organized lipid assemblies.

Authors:  R E Brown
Journal:  Biochim Biophys Acta       Date:  1992-12-11

Review 3.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 4.  Approaches to semi-synthetic minimal cells: a review.

Authors:  Pier Luigi Luisi; Francesca Ferri; Pasquale Stano
Journal:  Naturwissenschaften       Date:  2006-01

5.  Highly Efficient Protein-free Membrane Fusion: A Giant Vesicle Study.

Authors:  Rafael B Lira; Tom Robinson; Rumiana Dimova; Karin A Riske
Journal:  Biophys J       Date:  2018-12-01       Impact factor: 4.033

6.  Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.

Authors:  C Giraud; E Winocour; K I Berns
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

Authors:  W Li; J Fan; D Hochhauser; D Banerjee; Z Zielinski; A Almasan; Y Yin; R Kelly; G M Wahl; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Topical delivery of siRNA into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Michael Zakrewsky; Vivek Gupta; Aaron C Anselmo; Deborah H Slee; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

9.  Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Authors:  P R Kinchington; J P Vergnes; P Defechereux; J Piette; S E Turse
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  The role of helper lipids in cationic liposome-mediated gene transfer.

Authors:  S W Hui; M Langner; Y L Zhao; P Ross; E Hurley; K Chan
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.